Search Results 1521-1530 of 16176 for alt

  1. Low-Dose Selinexor and Choline Salicylate for the Treatment of Patients With Non-Hodgkin Lymphoma or Histiocytic/Dendritic Cell Neoplasms - Mayo Clinic

    ... (ALT) =< 2.5 x ULN (obtained =< 14 days prior to registration) - Calculated creatinine clearance must be >= 35 ml/min using the Cockcroft Gault formula ...

  2. Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers - Mayo Clinic

    Serum transaminases (alanine aminotransferase [ALT] and aspartate aminotransferase [AST]) ≤ 3 x ULN;; Glomerular Filtration Rate ≥ 50 mL/min (according to ...

  3. Oncolytic Adenovirus Coding for TNFa and IL2 (TILT-123) With Pembrolizumab or Pembrolizumab and Pegylated Liposomal Doxorubicin as Treatment for Ovarian Cancer. (PROTA) - Mayo Clinic

    total bilirubin levels >1.5 × ULN (excluding patients with Gilbert's Disease) ii. Aspartate Aminotransferase (AST) (SGOT) and Alanine Aminotransferase (ALT) ( ...

  4. A Study to Evaluate TAK-981 Given With Monoclonal Antibodies In Adults With Relapsed or Refractory Multiple Myeloma - Mayo Clinic

    AST (glutamic oxaloacetic transaminase [GOT]) and ALT (GPT) ≤ 3.0 × ULN; bilirubin ≤ 1.5 × ULN. Patients with Gilbert's syndrome may have a bilirubin ...

  5. MC230813 A Study of Golcadomide with Rituximab prior to CAR-T with Relapsed or Primary Refractory Aggressive B-cell Non-Hodgkin Lymphoma (NHL) - Mayo Clinic

    Alanine aminotransferase (ALT) and aspartate transaminase (AST); ≤2.5 x ULN (≤5 x ULN if there is evidence of parenchymal liver involvement with lymphoma) ...

  6. A Study to Evaluate VSV-hIFNbeta-NIS to Treat Patients with Relapsed/Refractory Multiple Myleoma, Acute Myeloid Leukemia, or T-cell Lymphoma - Mayo Clinic

    - Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) =< 2 times upper limit of normal (ULN) (obtained =< 15 days prior to registration)

  7. Ask the Mayo Mom: How and why endoscopy is used in children

    For more information and all your COVID-19 coverage, go to the Mayo Clinic News Network and mayoclinic.org. This image has an empty alt attribute; its file name ...

  8. Ulixertinib in People With Histiocytic Neoplasms - Mayo Clinic

    Adequate hepatic function (total bilirubin ≤1.5 times ULN, aspartate transaminase [AST] and- alanine transaminase [ALT] ≤3 times ULN or ≤5 times ULN if ...

  9. PTT-936, an Alpha Kinase 1 (ALPK1) Activator, Alone or in Combination with Anti-PD-1/L1 in Patients with Locally Advanced or Metastatic Solid Tumors - Mayo Clinic

    Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤ 3 x the upper limit of normal (ULN) with or without primary or metastatic liver tumor ...

  10. A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma - Mayo Clinic

    -Aspartate aminotransferase (AST, SGOT) and alanine aminotransferase (ALT, SGPT) ≤ 3 x ULN or ≤ 5 x ULN in cases of documented liver involvement.